{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T20:52:23Z","timestamp":1782766343564,"version":"3.54.5"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T00:00:00Z","timestamp":1528416000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4537-9","type":"journal-article","created":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T08:19:17Z","timestamp":1528445957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hereditary breast and ovarian cancer in Andalusian families: a genetic population study"],"prefix":"10.1186","volume":"18","author":[{"given":"Bella","family":"Pajares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Mar\u00eda","family":"Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Fern\u00e1ndez-de","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Muriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Alba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"M\u00e1rquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,8]]},"reference":[{"key":"4537_CR1","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ejhg.2008.212","volume":"17","author":"T Ripperger","year":"2009","unstructured":"Ripperger T, Gadzicki D, Meindl A, Schlegelberger B. Breast cancer susceptibility: current knowledge and implications for genetic counselling. Eur J Hum Genet. 2009;17:722\u201331.","journal-title":"Eur J Hum Genet"},{"key":"4537_CR2","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/nrc2054","volume":"7","author":"JD Fackenthal","year":"2007","unstructured":"Fackenthal JD, Olopade OI. Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer. 2007;7:937\u201348.","journal-title":"Nat Rev Cancer"},{"key":"4537_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/jmedgenet-2013-101974","volume":"51","author":"RM Brohet","year":"2014","unstructured":"Brohet RM, Velthuizen ME, Hogervorst FBL, Meijers-Heijboer HEJ, Seynaeve C, Coll\u00e9e MJ, et al. Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations. J Med Genet. 2014;51:98\u2013107.","journal-title":"J Med Genet"},{"key":"4537_CR4","unstructured":"BIC. Breast Cancer Information Core. \n                    https:\/\/research.nhgri.nih.gov\/bic\/\n                    \n                  . Accesed 31 Jan 2016."},{"key":"4537_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10689-009-9301-5","volume":"9","author":"O Diez","year":"2010","unstructured":"Diez O, Guti\u00e9rrez-Enr\u00edquez S, Balma\u00f1a J. Heterogeneous prevalence of recurrent BRCA1 and BRCA2 mutations in Spain according to the geographical area: implications for genetic testing. Familial Cancer. 2010;9:187\u201391.","journal-title":"Familial Cancer"},{"key":"4537_CR6","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s12094-011-0701-2","volume":"13","author":"B Gra\u00f1a","year":"2011","unstructured":"Gra\u00f1a B, Lastra E, Llort G, Brunet J, Isla D. SEOM clinical guidelines for hereditary cancer. Clin Transl Oncol. 2011;13:580\u20136.","journal-title":"Clin Transl Oncol"},{"key":"4537_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks596","volume":"40","author":"A Untergasser","year":"2012","unstructured":"Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth BC, Remm M, et al. Primer3--new capabilities and interfaces. Nucleic Acids Res. 2012;40:e115.","journal-title":"Nucleic Acids Res"},{"key":"4537_CR8","unstructured":"SNPCheck [Internet]. \n                    https:\/\/secure.ngrl.org.uk\/SNPCheck\/snpcheck.htm\n                    \n                  . Accesed 31 Jan 2016."},{"key":"4537_CR9","doi-asserted-by":"publisher","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","volume":"44","author":"MJ Landrum","year":"2016","unstructured":"Landrum MJ, Lee JM, Benson M, Brown G, Chao C, Chitipiralla S, et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 2016;44:D862\u20138.","journal-title":"Nucleic Acids Res"},{"key":"4537_CR10","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/humu.22981","volume":"37","author":"JT den Dunnen","year":"2016","unstructured":"den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, et al. HGVS recommendations for the description of sequence variants: 2016 update. Hum Mutat. 2016;37:564\u20139.","journal-title":"Hum Mutat"},{"key":"4537_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"4537_CR12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/(SICI)1098-1004(200001)15:1<86::AID-HUMU16>3.0.CO;2-4","volume":"15","author":"C B\u00e9roud","year":"2000","unstructured":"B\u00e9roud C, Collod-B\u00e9roud G, Boileau C, Soussi T, Junien C. UMD (universal mutation database): a generic software to build and analyze locus-specific databases. Hum Mutat. 2000;15:86\u201394.","journal-title":"Hum Mutat"},{"key":"4537_CR13","unstructured":"National Human Genome Research Institute. Open Access On-Line Breast Cancer Mutation Data Base. \n                    https:\/\/research.nhgri.nih.gov\/bic\/\n                    \n                  . Accesed 31 Jan 2016."},{"key":"4537_CR14","doi-asserted-by":"crossref","unstructured":"Cooper DN, Stenson PD, Chuzhanova NA. The Human Gene Mutation Database (HGMD) and its exploitation in the study of mutational mechanisms. Curr. Protoc. Bioinforma. 2006;Chapter 1:Unit 1.13.","DOI":"10.1002\/0471250953.bi0113s12"},{"key":"4537_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/humu.21438","volume":"32","author":"IFAC Fokkema","year":"2011","unstructured":"Fokkema IFAC, Taschner PEM, Schaafsma GCP, Celli J, Laros JFJ, den Dunnen JT. LOVD v.2.0: the next generation in gene variant databases. Hum. Mutat. 2011;32:557\u201363.","journal-title":"Mutat"},{"key":"4537_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248\u20139.","journal-title":"Nat Methods"},{"key":"4537_CR17","doi-asserted-by":"publisher","first-page":"15398","DOI":"10.1073\/pnas.0404380101","volume":"101","author":"PD Thomas","year":"2004","unstructured":"Thomas PD, Kejariwal A. Coding single-nucleotide polymorphisms associated with complex vs. Mendelian disease: evolutionary evidence for differences in molecular effects. Proc Natl Acad Sci U S A. 2004;101:15398\u2013403.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4537_CR18","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1093\/bioinformatics\/btl423","volume":"22","author":"E Capriotti","year":"2006","unstructured":"Capriotti E, Calabrese R, Casadio R. Predicting the insurgence of human genetic diseases associated to single point protein mutations with support vector machines and evolutionary information. Bioinformatics. 2006;22:2729\u201334.","journal-title":"Bioinformatics"},{"key":"4537_CR19","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1093\/nar\/gkm238","volume":"35","author":"Y Bromberg","year":"2007","unstructured":"Bromberg Y, Rost B. SNAP: predict effect of non-synonymous polymorphisms on function. Nucleic Acids Res. 2007;35:3823\u201335.","journal-title":"Nucleic Acids Res"},{"issue":"Suppl 3","key":"4537_CR20","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/1471-2164-14-S3-S2","volume":"14","author":"E Capriotti","year":"2013","unstructured":"Capriotti E, Altman RB, Bromberg Y. Collective judgment predicts disease-associated single nucleotide variants. BMC Genomics. 2013;14(Suppl 3):S2.","journal-title":"BMC Genomics"},{"key":"4537_CR21","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1093\/nar\/gkg509","volume":"31","author":"PC Ng","year":"2003","unstructured":"Ng PC, Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003;31:3812\u20134.","journal-title":"Nucleic Acids Res"},{"key":"4537_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkp215","volume":"37","author":"F-O Desmet","year":"2009","unstructured":"Desmet F-O, Hamroun D, Lalande M, Collod-B\u00e9roud G, Claustres M, B\u00e9roud C. Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009;37:e67.","journal-title":"Nucleic Acids Res"},{"key":"4537_CR23","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/nar\/29.5.1185","volume":"29","author":"M Pertea","year":"2001","unstructured":"Pertea M, Lin X, Salzberg SL. GeneSplicer: a new computational method for splice site prediction. Nucleic Acids Res. 2001;29:1185\u201390.","journal-title":"Nucleic Acids Res"},{"key":"4537_CR24","doi-asserted-by":"crossref","unstructured":"Sonnenburg S, R\u00e4tsch G, Jagota A, M\u00fcller KR. New Methods for Splice Site Recognition. Proc. Int. Conf. Artif. Neural Networks. 2002;","DOI":"10.1007\/3-540-46084-5_54"},{"key":"4537_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/humu.10295","volume":"23","author":"L Eng","year":"2004","unstructured":"Eng L, Coutinho G, Nahas S, Yeo G, Tanouye R, Babaei M, et al. Nonclassical splicing mutations in the coding and noncoding regions of the ATM gene: maximum entropy estimates of splice junction strengths. Hum Mutat. 2004;23:67\u201376.","journal-title":"Hum Mutat"},{"key":"4537_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046688","volume":"7","author":"Y Choi","year":"2012","unstructured":"Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. Predicting the functional effect of amino acid substitutions and indels. PLoS One. 2012;7:e46688.","journal-title":"PLoS One"},{"key":"4537_CR27","doi-asserted-by":"publisher","first-page":"10096","DOI":"10.1158\/0008-5472.CAN-05-1241","volume":"65","author":"T Judkins","year":"2005","unstructured":"Judkins T, Hendrickson BC, Deffenbaugh AM, Eliason K, Leclair B, Norton MJ, et al. Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations. Cancer Res. 2005;65:10096\u2013103.","journal-title":"Cancer Res"},{"key":"4537_CR28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/bioinformatics\/15.2.174","volume":"15","author":"J Rozas","year":"1999","unstructured":"Rozas J, Rozas R. DnaSP version 3: an integrated program for molecular population genetics and molecular evolution analysis. Bioinformatics. 1999;15:174\u20135.","journal-title":"Bioinformatics"},{"key":"4537_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/1098-1004(200008)16:2<123::AID-HUMU4>3.0.CO;2-Y","volume":"16","author":"C Szabo","year":"2000","unstructured":"Szabo C, Masiello A, Ryan JF, Brody LC. The breast cancer information core: database design, structure, and scope. Hum Mutat. 2000;16:123\u201331.","journal-title":"Hum Mutat"},{"key":"4537_CR30","doi-asserted-by":"publisher","first-page":"D992","DOI":"10.1093\/nar\/gkr1160","volume":"40","author":"S Caputo","year":"2012","unstructured":"Caputo S, Benboudjema L, Sinilnikova O, Rouleau E, B\u00e9roud C, Lidereau R, et al. Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1\/BRCA2 databases. Nucleic Acids Res. 2012;40:D992\u20131002.","journal-title":"Nucleic Acids Res"},{"key":"4537_CR31","doi-asserted-by":"crossref","unstructured":"Capalbo C, Ricevuto E, Vestri A, Ristori E, Sidoni T, Buffone O, et al. BRCA1 and BRCA2 genetic testing in Italian breast and\/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 2006;17 Suppl 7:vii34\u2013vii40.","DOI":"10.1093\/annonc\/mdl947"},{"key":"4537_CR32","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10549-008-0190-3","volume":"117","author":"L Papi","year":"2009","unstructured":"Papi L, Putignano AL, Congregati C, Zanna I, Sera F, Morrone D, et al. Founder mutations account for the majority of BRCA1-attributable hereditary breast\/ovarian cancer cases in a population from Tuscany. Central Italy Breast Cancer Res Treat. 2009;117:497\u2013504.","journal-title":"Central Italy Breast Cancer Res Treat"},{"key":"4537_CR33","doi-asserted-by":"publisher","first-page":"E1200","DOI":"10.1002\/humu.21202","volume":"31","author":"A Borg","year":"2010","unstructured":"Borg A, Haile RW, Malone KE, Capanu M, Diep A, T\u00f6rngren T, et al. Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study. Hum Mutat. 2010;31:E1200\u201340.","journal-title":"Hum Mutat"},{"key":"4537_CR34","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1136\/jmg.2007.056895","volume":"45","author":"C Bonnet","year":"2008","unstructured":"Bonnet C, Krieger S, Vezain M, Rousselin A, Tournier I, Martins A, et al. Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene. J Med Genet. 2008;45:438\u201346.","journal-title":"J Med Genet"},{"key":"4537_CR35","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/humu.21495","volume":"32","author":"PJ Whiley","year":"2011","unstructured":"Whiley PJ, Guidugli L, Walker LC, Healey S, Thompson BA, Lakhani SR, et al. Splicing and multifactorial analysis of intronic BRCA1 and BRCA2 sequence variants identifies clinically significant splicing aberrations up to 12 nucleotides from the intron\/exon boundary. Hum Mutat. 2011;32:678\u201387.","journal-title":"Hum Mutat"},{"key":"4537_CR36","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1373\/clinchem.2013.210658","volume":"60","author":"PJ Whiley","year":"2014","unstructured":"Whiley PJ, de la Hoya M, Thomassen M, Becker A, Brand\u00e3o R, Pedersen IS, et al. Comparison of mRNA splicing assay protocols across multiple laboratories: recommendations for best practice in standardized clinical testing. Clin Chem. 2014;60:341\u201352.","journal-title":"Clin Chem"},{"key":"4537_CR37","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/humu.22725","volume":"36","author":"A Acedo","year":"2015","unstructured":"Acedo A, Hern\u00e1ndez-Moro C, Curiel-Garc\u00eda \u00c1, D\u00edez-G\u00f3mez B, Velasco EA. Functional classification of BRCA2 DNA variants by splicing assays in a large minigene with 9 exons. Hum Mutat. 2015;36:210\u201321.","journal-title":"Hum Mutat"},{"key":"4537_CR38","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10549-006-9489-0","volume":"106","author":"E Beristain","year":"2007","unstructured":"Beristain E, Mart\u00ednez-Bouzas C, Guerra I, Viguera N, Moreno J, Iba\u00f1ez E, et al. Differences in the frequency and distribution of BRCA1 and BRCA2 mutations in breast\/ovarian cancer cases from the Basque country with respect to the Spanish population: implications for genetic counselling. Breast Cancer Res Treat. 2007;106:255\u201362.","journal-title":"Breast Cancer Res Treat"},{"key":"4537_CR39","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s10689-013-9622-2","volume":"12","author":"JI de Juan","year":"2013","unstructured":"de Juan JI, Garc\u00eda Casado Z, Palanca Suela S, Esteban Carde\u00f1osa E, L\u00f3pez Guerrero JA, Segura Huerta \u00c1, et al. Novel and recurrent BRCA1\/BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the program of genetic counseling in Cancer of Valencian community (eastern Spain). Relationship of family phenotypes with mutation prevalence. Familial Cancer. 2013;12:767\u201377.","journal-title":"Familial Cancer"},{"key":"4537_CR40","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s10549-007-9868-1","volume":"112","author":"MD Miramar","year":"2008","unstructured":"Miramar MD, Calvo MT, Rodriguez A, Ant\u00f3n A, Lorente F, Barrio E, et al. Genetic analysis of BRCA1 and BRCA2 in breast\/ovarian cancer families from Aragon (Spain): two novel truncating mutations and a large genomic deletion in BRCA1. Breast Cancer Res Treat. 2008;112:353\u20138.","journal-title":"Breast Cancer Res Treat"},{"key":"4537_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/sj.bjc.6603535","volume":"96","author":"E Levy-Lahad","year":"2007","unstructured":"Levy-Lahad E, Friedman E. Cancer risks among BRCA1 and BRCA2 mutation carriers. Br J Cancer. 2007;96:11\u20135.","journal-title":"Br J Cancer"},{"key":"4537_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.critrevonc.2006.01.006","volume":"59","author":"E Honrado","year":"2006","unstructured":"Honrado E, Ben\u00edtez J, Palacios J. Histopathology of BRCA1- and BRCA2-associated breast cancer. Crit Rev Oncol Hematol. 2006;59:27\u201339.","journal-title":"Crit Rev Oncol Hematol"},{"key":"4537_CR43","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000123846","volume":"75","author":"J Palacios","year":"2008","unstructured":"Palacios J, Robles Frias MJ, Castilla MA, Lopez-Garcia MA, Benitez J. The molecular pathology of hereditary breast Cancer. Pathobiology. 2008;75:85\u201394.","journal-title":"Pathobiology"},{"key":"4537_CR44","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/1471-2407-13-243","volume":"13","author":"P Blay","year":"2013","unstructured":"Blay P, Santamar\u00eda I, Pitiot AS, Luque M, Alvarado MG, Lastra A, et al. Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (northern Spain). BMC Cancer. 2013;13:243.","journal-title":"BMC Cancer"},{"key":"4537_CR45","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/humu.10260","volume":"22","author":"O D\u00edez","year":"2003","unstructured":"D\u00edez O, Osorio A, Dur\u00e1n M, Martinez-Ferrandis JI, de la Hoya M, Salazar R, et al. Analysis of BRCA1 and BRCA2 genes in Spanish breast\/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. Hum Mutat. 2003;22:301\u201312.","journal-title":"Hum Mutat"},{"key":"4537_CR46","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1157\/13115767","volume":"130","author":"E Esteban Carde\u00f1osa","year":"2008","unstructured":"Esteban Carde\u00f1osa E, Bolufer Gilabert P, Palanca Suela S, Barrag\u00e1n Gonz\u00e1lez E, Oltra Soler S, Chirivella Gonz\u00e1lez I, et al. BRCA1 and BRCA2 mutations in families studied in the program of genetic counselling in cancer of the Valencian community (Spain). Med. Clin. (Barc). 2008;130:121\u20136.","journal-title":"Med. Clin. (Barc)"},{"key":"4537_CR47","unstructured":"Mac\u00edas R. Trasmisi\u00f3n gen\u00e9tica del c\u00e1ncer en Extremadura. Valor pron\u00f3stico del consejo gen\u00e9tico. 2016. \n                    http:\/\/hdl.handle.net\/10662\/4165\n                    \n                  . Accesed 31 Dec 2016."},{"key":"4537_CR48","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s10038-006-0404-7","volume":"51","author":"M Infante","year":"2006","unstructured":"Infante M, Dur\u00e1n M, Esteban-Carde\u00f1osa E, Miner C, Velasco E. High proportion of novel mutations of BRCA1 and BRCA2 in breast\/ovarian cancer patients from Castilla-Le\u00f3n (Central Spain). J Hum Genet. 2006;51:611\u20137.","journal-title":"J Hum Genet"},{"key":"4537_CR49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1017\/S0003480001001014","volume":"66","author":"A Vega","year":"2002","unstructured":"Vega A, Torres M, Mart\u00ednez JI, Ruiz-Ponte C, Barros F, Carracedo A. Analysis of BRCA1 and BRCA2 in breast and breast\/ovarian cancer families shows population substructure in the Iberian peninsula. Ann Hum Genet. 2002;66:29\u201336.","journal-title":"Ann Hum Genet"},{"key":"4537_CR50","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/humu.1136","volume":"17","author":"A Vega","year":"2001","unstructured":"Vega A, Campos B, Bressac-De-Paillerets B, Bond PM, Janin N, Douglas FS, et al. The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript. Hum Mutat. 2001;17:520\u20131.","journal-title":"Hum Mutat"},{"key":"4537_CR51","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/ng1095-198","volume":"11","author":"JP Struewing","year":"1995","unstructured":"Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet. 1995;11:198\u2013200.","journal-title":"Nat Genet"},{"key":"4537_CR52","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/ng1096-185","volume":"14","author":"BB Roa","year":"1996","unstructured":"Roa BB, Boyd AA, Volcik K, Richards CS. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet. 1996;14:185\u20137.","journal-title":"Nat Genet"},{"key":"4537_CR53","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.1002\/cncr.27556","volume":"118","author":"T Judkins","year":"2012","unstructured":"Judkins T, Rosenthal E, Arnell C, Burbidge LA, Geary W, Barrus T, et al. Clinical significance of large rearrangements in BRCA1 and BRCA2. Cancer. 2012;118:5210\u20136.","journal-title":"Cancer"},{"key":"4537_CR54","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.canlet.2005.03.006","volume":"233","author":"R Salazar","year":"2006","unstructured":"Salazar R, Cruz-Hernandez JJ, Sanchez-Valdivieso E, Rodriguez CA, Gomez-Bernal A, Barco E, et al. BRCA1-2 mutations in breast cancer: identification of nine new variants of BRCA1-2 genes in a population from central western Spain. Cancer Lett. 2006;233:172\u20137.","journal-title":"Cancer Lett"},{"key":"4537_CR55","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1136\/jmg.2005.033258","volume":"43","author":"PK Lovelock","year":"2006","unstructured":"Lovelock PK, Healey S, Au W, Sum EYM, Tesoriero A, Wong EM, et al. Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants. J Med Genet. 2006;43:74\u201383.","journal-title":"J Med Genet"},{"key":"4537_CR56","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10689-010-9395-9","volume":"10","author":"M Sagi","year":"2011","unstructured":"Sagi M, Eilat A, Ben Avi L, Goldberg Y, Bercovich D, Hamburger T, et al. Two BRCA1\/2 founder mutations in Jews of Sephardic origin. Familial Cancer. 2011;10:59\u201363.","journal-title":"Familial Cancer"},{"key":"4537_CR57","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/humu.9188","volume":"22","author":"JI Mart\u00ednez-Ferrandis","year":"2003","unstructured":"Mart\u00ednez-Ferrandis JI, Vega A, Chirivella I, Mar\u00edn-Garc\u00eda P, Insa A, Lluch A, et al. Mutational analysis of BRCA1 and BRCA2 in Mediterranean Spanish women with early-onset breast cancer: identification of three novel pathogenic mutations. Hum Mutat. 2003;22:417\u20138.","journal-title":"Hum Mutat"},{"key":"4537_CR58","doi-asserted-by":"crossref","unstructured":"Cherbal F, Bakour R, Adane S, Boualga K. BRCA1 and BRCA2 germline mutation spectrum in hereditary breast\/ovarian cancer families from Maghrebian countries. Breast dis. [internet], Available from. 2012;34:1\u20138. \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23697973","DOI":"10.3233\/BD-130348"},{"key":"4537_CR59","unstructured":"SpainMDB (Spain Mutation DataBase). \n                    http:\/\/spainmdb.isciii.es\n                    \n                  \/. Accesed 31 Jan 2016."},{"key":"4537_CR60","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1158\/1078-0432.CCR-08-1417","volume":"15","author":"ME Sehl","year":"2009","unstructured":"Sehl ME, Langer LR, Papp JC, Kwan L, Seldon JL, Arellano G, et al. Associations between single nucleotide polymorphisms in double-stranded DNA repair pathway genes and familial breast cancer. Clin Cancer Res. 2009;15:2192\u2013203.","journal-title":"Clin Cancer Res"},{"key":"4537_CR61","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1158\/1055-9965.EPI-09-0447","volume":"18","author":"SL Dombernowsky","year":"2009","unstructured":"Dombernowsky SL, Weischer M, Freiberg JJ, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. Missense polymorphisms in BRCA1 and BRCA2 and risk of breast and ovarian cancer. Cancer Epidemiol Biomark Prev. 2009;18:2339\u201342.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"4537_CR62","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1007\/s12032-012-0294-9","volume":"29","author":"A Juwle","year":"2012","unstructured":"Juwle A, Saranath D. BRCA1\/BRCA2 gene mutations\/SNPs and BRCA1 haplotypes in early-onset breast cancer patients of Indian ethnicity. Med Oncol. 2012;29:3272\u201381.","journal-title":"Med Oncol"},{"key":"4537_CR63","doi-asserted-by":"publisher","first-page":"7516","DOI":"10.1158\/0008-5472.CAN-05-0132","volume":"65","author":"ML Freedman","year":"2005","unstructured":"Freedman ML, Penney KL, Stram DO, Riley S, McKean-Cowdin R, Le Marchand L, et al. A haplotype-based case-control study of BRCA1 and sporadic breast cancer risk. Cancer Res. 2005;65:7516\u201322.","journal-title":"Cancer Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4537-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4537-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4537-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T19:12:12Z","timestamp":1559934732000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4537-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,8]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4537"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4537-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,8]]},"assertion":[{"value":"30 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by Research Ethics Committee of the University Hospital Virgen de la Victoria (Malaga). All tested individuals provided a signed informed consent following the appropriate genetic counselling.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"647"}}